Gut microbiota develop towards an adult profile in a sex-specific manner during puberty.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 12 2021
Historique:
received: 02 06 2021
accepted: 12 11 2021
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 1 2 2022
Statut: epublish

Résumé

Accumulating evidence indicates that gut microbiota may regulate sex-hormone levels in the host, with effects on reproductive health. Very little is known about the development of intestinal microbiota during puberty in humans. To assess the connection between pubertal timing and fecal microbiota, and to assess how fecal microbiota develop during puberty in comparison with adult microbiota, we utilized a Finnish allergy-prevention-trial cohort (Flora). Data collected at 13-year follow-up were compared with adult data from a different Finnish cohort. Among the 13-year-old participants we collected questionnaire information, growth data from school-health-system records and fecal samples from 148 participants. Reference adult fecal samples were received from the Health and Early Life Microbiota (HELMi) cohort (n = 840). Fecal microbiota were analyzed using 16S rRNA gene amplicon sequencing; the data were correlated with pubertal timing and compared with data on adult microbiota. Probiotic intervention in the allergy-prevention-trial cohort was considered as a confounding factor only. The main outcome was composition of the microbiota in relation to pubertal timing (time to/from peak growth velocity) in both sexes separately, and similarity to adult microbiota. In girls, fecal microbiota became more adult-like with pubertal progression (p = 0.009). No such development was observed in boys (p = 0.9). Both sexes showed a trend towards increasing relative abundance of estrogen-metabolizing Clostridia and decreasing Bacteroidia with pubertal development, but this was statistically significant in girls only (p = 0.03). In girls, pubertal timing was associated positively with exposure to cephalosporins prior to the age of 10. Our data support the hypothesis that gut microbiota, particularly members of Ruminococcaceae, may affect pubertal timing, possibly via regulating host sex-hormone levels.Trial registration The registration number for the allergy-prevention-trial cohort: ClinicalTrials.gov, NCT00298337, registered 1 March 2006-Retrospectively registered, https://clinicaltrials.gov/show/NCT00298337 . The adult-comparison cohort (HELMi) is NCT03996304.

Identifiants

pubmed: 34857814
doi: 10.1038/s41598-021-02375-z
pii: 10.1038/s41598-021-02375-z
pmc: PMC8640005
doi:

Substances chimiques

Estrogens 0

Banques de données

ClinicalTrials.gov
['NCT03996304', 'NCT00298337']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23297

Informations de copyright

© 2021. The Author(s).

Références

Am J Clin Nutr. 1991 Sep;54(3):520-5
pubmed: 1652197
J Pediatr. 2021 Mar;230:221-229.e5
pubmed: 33253732
Science. 2016 Feb 19;351(6275):
pubmed: 26912898
Front Endocrinol (Lausanne). 2019 Nov 08;10:758
pubmed: 31781033
J Clin Endocrinol Metab. 2014 Dec;99(12):4632-40
pubmed: 25211668
Immunity. 2013 Aug 22;39(2):400-12
pubmed: 23973225
Nat Genet. 2017 Jun;49(6):834-841
pubmed: 28436984
Microb Pathog. 2017 May;106:162-170
pubmed: 27836763
Front Microbiol. 2017 Feb 28;8:324
pubmed: 28293234
Arch Dis Child. 1992 Oct;67(10):1277-80
pubmed: 1444528
J Neuroendocrinol. 2019 Jun;31(6):e12719
pubmed: 30963653
PLoS One. 2016 Apr 19;11(4):e0153196
pubmed: 27093642
PLoS One. 2013 May 23;8(5):e64315
pubmed: 23717595
Microbiome. 2015 Aug 26;3:36
pubmed: 26306392
FEMS Microbiol Ecol. 2011 Aug;77(2):404-12
pubmed: 21539582
Front Microbiol. 2018 Jun 05;9:1210
pubmed: 29922272
Curr Opin Microbiol. 2018 Aug;44:70-78
pubmed: 30086431
PLoS One. 2009 Dec 24;4(12):e8450
pubmed: 20041184
BMJ Open. 2019 Jun 27;9(6):e028500
pubmed: 31253623
Microb Cell Fact. 2020 Jul 28;19(1):152
pubmed: 32723385
Gut Microbes. 2016 Jul 3;7(4):313-322
pubmed: 27355107
Gut. 2019 Jan;68(1):62-69
pubmed: 30377188
Microbiome. 2019 Jan 4;7(1):2
pubmed: 30609941
Front Endocrinol (Lausanne). 2020 Jan 22;10:941
pubmed: 32038493
Int J Environ Res Public Health. 2017 Nov 13;14(11):
pubmed: 29137163
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7554-E7563
pubmed: 27821775
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Best Pract Res Clin Endocrinol Metab. 2019 Jun;33(3):101275
pubmed: 31047817
J Transl Med. 2012 Dec 21;10:253
pubmed: 23259758
J Biol Chem. 2019 Dec 6;294(49):18586-18599
pubmed: 31636122
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Science. 2013 Mar 1;339(6123):1084-8
pubmed: 23328391
Annu Rev Food Sci Technol. 2018 Mar 25;9:65-84
pubmed: 29298101
Minerva Pediatr. 2017 Oct;69(5):415-426
pubmed: 28745464
Microbiome. 2017 Mar 3;5(1):26
pubmed: 28253911
Clin Exp Allergy. 2019 Apr;49(4):506-515
pubmed: 30472801
Microbiome. 2018 Oct 16;6(1):182
pubmed: 30326954
J Allergy Clin Immunol. 2009 Feb;123(2):335-41
pubmed: 19135235
BMC Microbiol. 2020 Nov 3;20(1):334
pubmed: 33143658
J Allergy Clin Immunol. 2007 Jan;119(1):192-8
pubmed: 17208601
Maturitas. 2017 Sep;103:45-53
pubmed: 28778332
ISME J. 2014 Nov;8(11):2218-30
pubmed: 24763370
Pediatrics. 2018 Dec;142(6):
pubmed: 30381474
J Microbiol Methods. 2010 May;81(2):127-34
pubmed: 20171997
Maturitas. 2018 Oct;116:43-53
pubmed: 30244778
Cancer. 1994 Aug 1;74(3 Suppl):1125-31
pubmed: 8039147

Auteurs

Katri Korpela (K)

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014, Helsinki, Finland.

Sampo Kallio (S)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland. sampo.kallio@helsinki.fi.

Anne Salonen (A)

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014, Helsinki, Finland.

Matti Hero (M)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Anna Kaarina Kukkonen (AK)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Päivi J Miettinen (PJ)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Erkki Savilahti (E)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Ella Kohva (E)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Laura Kariola (L)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Maria Suutela (M)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Annika Tarkkanen (A)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Willem M de Vos (WM)

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014, Helsinki, Finland.
Laboratory of Microbiology, Wageningen University, Stippeneng 4, P.O. Box 8033, 6700 EH, Wageningen, The Netherlands.

Taneli Raivio (T)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.
Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Yliopistonkatu 3, P.O. Box 4, 00014, Helsinki, Finland.

Mikael Kuitunen (M)

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Stenbäckinkatu 9, P.O. Box 347, 00029, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH